SlideShare a Scribd company logo
NEOPLASIA
Characteristics/ Classification of
Neoplasms
Definition
that
• Neoplasia means ‘new growth’
• Neoplasm means ‘tumour/ cancer’
• Cancer is an uncontrolled proliferation of cells
express varying degree of fidelity to their precursors.
• It can be benign or malignant.
• Benign: Cells grow as a compact
mass and remain at their site of
origin
• Malignant:
Growth of cells is uncontrolled
Cells can spread into surrounding
tissue and spread to distant sites.
Cellular adaptations
Cellular adaptations
• Atrophy: Reduction of number and size of parenchymal cells
of an organ or its parts which was once normal is called
atrophy. E.g.: ischemic atrophy, neuropathic atrophy.
• Hypertrophy: Increase is an size of parenchymal cells resulting
in enlargement of the organ. E.g.: enlarged size of uterus in
pregnancy (physiological), hypertrophy of cardiac muscle
(pathological).
Cellular adaptations
• Hyperplasia: Increased number of parenchymal cells resulting
in enlargement of the organ. E.g.: Hyperplasia of female
breast at puberty, pregnancy and lactation
during
(physiological), wound healing (pathological; formation of
granulation tissue due to proliferation of fibroblasts and
endothelial cells)
• Dysplasia: Disordered cellular development (pleomorphism,
nuclear hyperchromasia, mitosis, loss of polarity)
accompanied with metaplasia and hyperplasia.
• Metaplasia: Reversible changes in one type of epithelial or
epithelial or
mesenchymal adult cell to another type of
mesenchymal adult cell .
– Epithelial  Squamous and Columnar metaplasia
– Mesenchymal  Osseous and Cartilaginous metaplasia
Differences between normal and
cancer cell
Differences between benign and
malignant neoplasms
BENIGN MALIGNANT
Nuclear variation in
size and shape
minimal
Nuclear variation in size and
shape minimal to marked,
often variable
Diploid Range of ploidy
Low mitotic count,
normal mitosis
Low to high mitotic count,
abnormal mitosis
Retention of
specialisation
Loss of specialisation
Structural
differentiation
retained
Structural differentiation shows
wide range of changes
Organised Not organised
Functional
differentiation
usually
Functional differentiation often
lost
Causes of cancer
Three major type of carcinogens
Chemical carcinogenesis
• Mutagens
• Chemical carcinogenesis and their metabolism
Physical carcinogenesis (radiation)
• Ultraviolet radiation, Asbestos
Infectious Pathogens (Viral)
• Human T-cell leukemia viruses, DNA
viruses, Human papillomaviruses
• Epstein-Barr virus, Hepatitis B virus
Development of cancer
• Changes in DNA (mutation)
• The change must cause an alteration in cell growth and behaviour
• The change must be non-lethal and be passed onto daughter cells
• Alterations in more than one gene
• Genes concerned are oncogenes/tumour suppressor genes
• Sequence of gene alterations from normal to benign to malignant
• Intrinsic and extrinsic / inheritance and environment key factors
Properties of cancer cells
• Tow unique properties of cancer cells are
– ability to invade locally
– capacity to metastasize to distant sites to distant sites – cancer
spreading (patterns of spread)
Patterns of spread:
Direct extension: Carcinomas begin as
localized growths (direct seeding of body
cavities or surface), when they arise. In
early cancers do not penetrate the
basement membrane (carcinoma in situ).
When the in situ tumor acquires invasive
potential extends directly to compromise
neighboring cells and to metastasize. E.g.
Peritoneal carcinomatosis (metastatic
ovarian carcinoma)
Properties of cancer cells
• Patterns of spread:
– Direct extension
– Metastatic spread: Transfer of
malignant cells from one site to
another (not directly connected
with it). Invasive properties of
malignant tumors bring them into
contact with blood and lymphatic
vessels.
• Hematogenous metastases
• Lymphatic metastases
Nomenclature
• Benign tumors:
– Suffix- oma to cell of origin
– Name of origin cell + morphologic
pailoma, ovarian cyst adenoma)
character + oma (skin
– E.g.:
• tumors of squamous epithelium- epithelioma
• tumors arising from the glandular gland (colon/ endocrine glands)-
adenoma
– lipoma ,fiboma, chondroma, osteoma papilloma
Nomenclature
• Malignant tumors:
– mesenchymal tissue are usually called sarcoma
– Epithelial cell origin are usually called carcinoma
– Name of origin cell + morphologic character + carcinoma/
sarcoma
– E.g.:
• Malignant tumor of the stomach is a gastric adenocarcinoma or
adenocarcinoma of the stomach.
Special nomenclature
• Blastoma: tumors rigging in immature tissue or nervous
tissue, most of them are malignant
– E.g.: medulloblastoma, retinoblastoma, nephroblastoma
• Some tumors ataching the suffix- oma, but they are malignant
Malignant tumor of the liver: Hepatoma
Melanoma of the skin
Lymphoproferative tumor: Lymphoma (Hodgkin’s
and non Hodgkin’s)
Malignant proliferation of leukocytes: Leukemia
Special nomenclature
• Mixed tumors: Derived from one from one germ layer
may undergo divergent defferentiation creating
– E.g.: Mixed tumor of salivary gland
• Teratomas: Tumors containing mature or immature cells
• Hamartoma: tumor-like malformation composed of a
haphazard arrangement of tissues indigenous to the
particular site, which is totally benign.
Classification of tumours
Classification of tumours
Characteristics of tumours
• Majority of neoplasms can be categorized clinically and
morphological into benign and malignant on the basis of
certain characteristics listed bellow
– Rate of growth
– Cancer phenotype and stem cells
– Clinical and gross features
– Microscopic features
– Local invasion (direct spread)
– Metastasis (distant spread)
Characteristics of tumours
• Rate of growth
– The tumour cell proliferate more rapidly than the normal cells.
– The tumour enlarge rate is depends upon
1. Rate of cell production, growth fraction and rate of cell loss
2. Degree of differentiation of the tumour
1. Rate of growth of a tumour depends upon
• Doubling time (mitotic rate) of tumour cells
• Number of cells remaining in preoperative pool (growth fraction)
• Rate of loss of tumour cells by cell shedding
Cancer cell do not follow the normal cell controls in cells, and are immortal.
The cell division rate is high and center of tumor do not receive adequate
nourishment and undergo ischemic necrosis, loss shedding.
Death tumour cells appear as apoptotic figures and dividing tumours are
seen as normal/ abnormal mitotic figure ultimately tumour grow in size.
Characteristics of tumours
• Rate of growth
2. Degree of differentiation
• Rate of growth of malignant tumour is directly proportionate to the
degree of differentiation.
• Poorly differentiated tumours show aggressive growth pattern
compare to better differentiated tumours.
• Rarely, a malignant tumour may disappear spontaneously from the
primary site, due to good host immune attack.
Characteristics of tumours
• Cancer phenotype and stem cells
Cancer cells
1. disobey the growth control – proliferate rapidly
2. escape from death signals – immortality
3. imbalance between cell proliferation and cell death – excessive growth
4. lose differentiation properties – no function
5. are unstable – newer mutations
6. overrun their neighboring tissue – invade locally
7. have the ability to travel from the site of origin to other part of body –
distant metastasis
Cancer stem cells/ tumour-initiating cells have the properties of self-renewal,
asymmetric replication and transdifferentiation (i.e. plasticity).
Characteristics of tumours
• Clinical and gross features
– Benign tumour are generally slow growing and depending
upon location remains asymptomatic (subcutaneous lipoma)
or may cause serous symptoms (meningioma in the nervous
system). Benign tumours are generally spherical or ovoid
shape.
– Malignant tumor grow rapidly, invade locally into deeper
tissue and spread to distant sites (metastasis). Malignant
tumours are usually irregular in shape, poor-circumscribed
and extend into adjacent tissues.
Characteristics of tumours
• Microscopic features
– Microscopic pattern
– Cytomorphology of neoplastic cells
– Tumor angiogenesis and stroma
– Inflammatory reaction
Characteristics of tumours
• Local invasion (direct spread)
– Benign: expand and push aside without invading, infiltrating
or metastasising.
– Malignant: expand, invasion, infiltration and destruction of
the surrounding tissue.
• Metastasis (distant spread)
– Metastasis (meta= transformation, stasis= residence): spread
of tumour by invasion.
– Routes of metastasis
• Lymphatic spread
• Haematogenous spread
• Spread along body cavities and natural passages
Tumours grading
Grading is based on (1) the degree of anaplasia
(2) the rate of growth
• Grade-I : Well-differentiated (less than 25% anaplastic cells)
• Grade-II : Moderately-differentiated (25-50% anaplastic cells)
• Grade-III : Moderately-differentiated (50-75% anaplastic cells)
• Grade-IV : Poorly-differentiated or anaplastic (more than 75%
anaplastic cells)
Tumours staging
• International TNM system is commonly used for solid
tumours (less applicable to lymphomas and leukaemias).
– T: Tumour (size of primary tumour), N: Nodes (local/ regional
node involvement), M: Metastases (distant metastases)
T0 No evidence of tumour N0 Regional lymph nodes not involved
Tis Carcinoma in situ NX Regional lymph nodes can’t be
assessed
TX Tumour can’t be
assessed
N1-4 Progressive increase in number of
local/ regional lymph nodes involved
T1-4 Progressive increase in
tumour size
M0 No evidence of distant metastases
MX distant metastases can’t be assessed
M1-3 Increasing involvement of distant
metastases

More Related Content

Similar to neoplasia.pptx

TUMOR MARKERS.......................pptx
TUMOR MARKERS.......................pptxTUMOR MARKERS.......................pptx
TUMOR MARKERS.......................pptx
ahamdsarayreh
 
Neoplasia 1
Neoplasia 1 Neoplasia 1
Neoplasia - Characteristics & Classification of Neoplasm
Neoplasia - Characteristics & Classification of Neoplasm           Neoplasia - Characteristics & Classification of Neoplasm
Neoplasia - Characteristics & Classification of Neoplasm
Chhavi Singh
 
Oncology
OncologyOncology
biology of cancer
biology of cancerbiology of cancer
biology of cancer
KAUSHAL SAHU
 
9. neoplasia
9. neoplasia9. neoplasia
9. neoplasia
Saugat Chapagain
 
neoplasia 1
 neoplasia  1 neoplasia  1
neoplasia 1
MINDS MAHE
 
Neoplasia by dr,ahmed alshujery
 Neoplasia by dr,ahmed alshujery Neoplasia by dr,ahmed alshujery
Neoplasia by dr,ahmed alshujery
Dr-Ahmed Alshujery
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
Navisrani
 
neoplasia , carcinogenesis, tumour market
neoplasia , carcinogenesis, tumour marketneoplasia , carcinogenesis, tumour market
neoplasia , carcinogenesis, tumour market
HardLife1
 
Neplasia
NeplasiaNeplasia
Neplasia
Jomin George
 
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
CANCER:  A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSISCANCER:  A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
Charu Pundir
 
ONCOLOGY.pptx
ONCOLOGY.pptxONCOLOGY.pptx
ONCOLOGY.pptx
georginansiah247
 
Neoplasia presentation complete .ppt material
Neoplasia presentation  complete .ppt materialNeoplasia presentation  complete .ppt material
Neoplasia presentation complete .ppt material
AmanuelIbrahim
 
Cancer
Cancer Cancer
Neoplasma 1
Neoplasma 1Neoplasma 1
Neoplasma 1
Tri Kurniawan
 
neoplasia final.pptx
neoplasia final.pptxneoplasia final.pptx
neoplasia final.pptx
VandanaChandan1
 

Similar to neoplasia.pptx (20)

TUMOR MARKERS.......................pptx
TUMOR MARKERS.......................pptxTUMOR MARKERS.......................pptx
TUMOR MARKERS.......................pptx
 
Tumours
TumoursTumours
Tumours
 
Neoplasia.pptx
Neoplasia.pptxNeoplasia.pptx
Neoplasia.pptx
 
Neoplasia 1
Neoplasia 1 Neoplasia 1
Neoplasia 1
 
Neoplasia - Characteristics & Classification of Neoplasm
Neoplasia - Characteristics & Classification of Neoplasm           Neoplasia - Characteristics & Classification of Neoplasm
Neoplasia - Characteristics & Classification of Neoplasm
 
Oncology
OncologyOncology
Oncology
 
biology of cancer
biology of cancerbiology of cancer
biology of cancer
 
9. neoplasia
9. neoplasia9. neoplasia
9. neoplasia
 
neoplasia 1
 neoplasia  1 neoplasia  1
neoplasia 1
 
Neoplasia by dr,ahmed alshujery
 Neoplasia by dr,ahmed alshujery Neoplasia by dr,ahmed alshujery
Neoplasia by dr,ahmed alshujery
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
 
neoplasia , carcinogenesis, tumour market
neoplasia , carcinogenesis, tumour marketneoplasia , carcinogenesis, tumour market
neoplasia , carcinogenesis, tumour market
 
Neplasia
NeplasiaNeplasia
Neplasia
 
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
CANCER:  A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSISCANCER:  A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSIS
 
ONCOLOGY.pptx
ONCOLOGY.pptxONCOLOGY.pptx
ONCOLOGY.pptx
 
Cancer
CancerCancer
Cancer
 
Neoplasia presentation complete .ppt material
Neoplasia presentation  complete .ppt materialNeoplasia presentation  complete .ppt material
Neoplasia presentation complete .ppt material
 
Cancer
Cancer Cancer
Cancer
 
Neoplasma 1
Neoplasma 1Neoplasma 1
Neoplasma 1
 
neoplasia final.pptx
neoplasia final.pptxneoplasia final.pptx
neoplasia final.pptx
 

More from RusudanTchighvaria

BIOCHEMISTRY 2
BIOCHEMISTRY 2BIOCHEMISTRY 2
BIOCHEMISTRY 2
RusudanTchighvaria
 
purine metabolism.ppt
purine metabolism.pptpurine metabolism.ppt
purine metabolism.ppt
RusudanTchighvaria
 
pyrimidine metabolism.pptx
pyrimidine metabolism.pptxpyrimidine metabolism.pptx
pyrimidine metabolism.pptx
RusudanTchighvaria
 
metabolism (1).ppt
metabolism (1).pptmetabolism (1).ppt
metabolism (1).ppt
RusudanTchighvaria
 
enzymes.ppt
enzymes.pptenzymes.ppt
enzymes.ppt
RusudanTchighvaria
 
Extracellular Matrix.pptx
Extracellular Matrix.pptxExtracellular Matrix.pptx
Extracellular Matrix.pptx
RusudanTchighvaria
 
enzymes pres.ppt
enzymes pres.pptenzymes pres.ppt
enzymes pres.ppt
RusudanTchighvaria
 
Fat -soluble vitamins.pptx
Fat -soluble  vitamins.pptxFat -soluble  vitamins.pptx
Fat -soluble vitamins.pptx
RusudanTchighvaria
 
apoptosis cancer biology.pptx
apoptosis cancer biology.pptxapoptosis cancer biology.pptx
apoptosis cancer biology.pptx
RusudanTchighvaria
 
collagen.pptx
collagen.pptxcollagen.pptx
collagen.pptx
RusudanTchighvaria
 

More from RusudanTchighvaria (10)

BIOCHEMISTRY 2
BIOCHEMISTRY 2BIOCHEMISTRY 2
BIOCHEMISTRY 2
 
purine metabolism.ppt
purine metabolism.pptpurine metabolism.ppt
purine metabolism.ppt
 
pyrimidine metabolism.pptx
pyrimidine metabolism.pptxpyrimidine metabolism.pptx
pyrimidine metabolism.pptx
 
metabolism (1).ppt
metabolism (1).pptmetabolism (1).ppt
metabolism (1).ppt
 
enzymes.ppt
enzymes.pptenzymes.ppt
enzymes.ppt
 
Extracellular Matrix.pptx
Extracellular Matrix.pptxExtracellular Matrix.pptx
Extracellular Matrix.pptx
 
enzymes pres.ppt
enzymes pres.pptenzymes pres.ppt
enzymes pres.ppt
 
Fat -soluble vitamins.pptx
Fat -soluble  vitamins.pptxFat -soluble  vitamins.pptx
Fat -soluble vitamins.pptx
 
apoptosis cancer biology.pptx
apoptosis cancer biology.pptxapoptosis cancer biology.pptx
apoptosis cancer biology.pptx
 
collagen.pptx
collagen.pptxcollagen.pptx
collagen.pptx
 

Recently uploaded

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 

Recently uploaded (20)

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 

neoplasia.pptx

  • 2. Definition that • Neoplasia means ‘new growth’ • Neoplasm means ‘tumour/ cancer’ • Cancer is an uncontrolled proliferation of cells express varying degree of fidelity to their precursors. • It can be benign or malignant. • Benign: Cells grow as a compact mass and remain at their site of origin • Malignant: Growth of cells is uncontrolled Cells can spread into surrounding tissue and spread to distant sites.
  • 4. Cellular adaptations • Atrophy: Reduction of number and size of parenchymal cells of an organ or its parts which was once normal is called atrophy. E.g.: ischemic atrophy, neuropathic atrophy. • Hypertrophy: Increase is an size of parenchymal cells resulting in enlargement of the organ. E.g.: enlarged size of uterus in pregnancy (physiological), hypertrophy of cardiac muscle (pathological).
  • 5. Cellular adaptations • Hyperplasia: Increased number of parenchymal cells resulting in enlargement of the organ. E.g.: Hyperplasia of female breast at puberty, pregnancy and lactation during (physiological), wound healing (pathological; formation of granulation tissue due to proliferation of fibroblasts and endothelial cells) • Dysplasia: Disordered cellular development (pleomorphism, nuclear hyperchromasia, mitosis, loss of polarity) accompanied with metaplasia and hyperplasia. • Metaplasia: Reversible changes in one type of epithelial or epithelial or mesenchymal adult cell to another type of mesenchymal adult cell . – Epithelial  Squamous and Columnar metaplasia – Mesenchymal  Osseous and Cartilaginous metaplasia
  • 6. Differences between normal and cancer cell
  • 7. Differences between benign and malignant neoplasms BENIGN MALIGNANT Nuclear variation in size and shape minimal Nuclear variation in size and shape minimal to marked, often variable Diploid Range of ploidy Low mitotic count, normal mitosis Low to high mitotic count, abnormal mitosis Retention of specialisation Loss of specialisation Structural differentiation retained Structural differentiation shows wide range of changes Organised Not organised Functional differentiation usually Functional differentiation often lost
  • 8. Causes of cancer Three major type of carcinogens Chemical carcinogenesis • Mutagens • Chemical carcinogenesis and their metabolism Physical carcinogenesis (radiation) • Ultraviolet radiation, Asbestos Infectious Pathogens (Viral) • Human T-cell leukemia viruses, DNA viruses, Human papillomaviruses • Epstein-Barr virus, Hepatitis B virus
  • 9. Development of cancer • Changes in DNA (mutation) • The change must cause an alteration in cell growth and behaviour • The change must be non-lethal and be passed onto daughter cells • Alterations in more than one gene • Genes concerned are oncogenes/tumour suppressor genes • Sequence of gene alterations from normal to benign to malignant • Intrinsic and extrinsic / inheritance and environment key factors
  • 10.
  • 11. Properties of cancer cells • Tow unique properties of cancer cells are – ability to invade locally – capacity to metastasize to distant sites to distant sites – cancer spreading (patterns of spread) Patterns of spread: Direct extension: Carcinomas begin as localized growths (direct seeding of body cavities or surface), when they arise. In early cancers do not penetrate the basement membrane (carcinoma in situ). When the in situ tumor acquires invasive potential extends directly to compromise neighboring cells and to metastasize. E.g. Peritoneal carcinomatosis (metastatic ovarian carcinoma)
  • 12. Properties of cancer cells • Patterns of spread: – Direct extension – Metastatic spread: Transfer of malignant cells from one site to another (not directly connected with it). Invasive properties of malignant tumors bring them into contact with blood and lymphatic vessels. • Hematogenous metastases • Lymphatic metastases
  • 13. Nomenclature • Benign tumors: – Suffix- oma to cell of origin – Name of origin cell + morphologic pailoma, ovarian cyst adenoma) character + oma (skin – E.g.: • tumors of squamous epithelium- epithelioma • tumors arising from the glandular gland (colon/ endocrine glands)- adenoma – lipoma ,fiboma, chondroma, osteoma papilloma
  • 14. Nomenclature • Malignant tumors: – mesenchymal tissue are usually called sarcoma – Epithelial cell origin are usually called carcinoma – Name of origin cell + morphologic character + carcinoma/ sarcoma – E.g.: • Malignant tumor of the stomach is a gastric adenocarcinoma or adenocarcinoma of the stomach.
  • 15. Special nomenclature • Blastoma: tumors rigging in immature tissue or nervous tissue, most of them are malignant – E.g.: medulloblastoma, retinoblastoma, nephroblastoma • Some tumors ataching the suffix- oma, but they are malignant Malignant tumor of the liver: Hepatoma Melanoma of the skin Lymphoproferative tumor: Lymphoma (Hodgkin’s and non Hodgkin’s) Malignant proliferation of leukocytes: Leukemia
  • 16. Special nomenclature • Mixed tumors: Derived from one from one germ layer may undergo divergent defferentiation creating – E.g.: Mixed tumor of salivary gland • Teratomas: Tumors containing mature or immature cells • Hamartoma: tumor-like malformation composed of a haphazard arrangement of tissues indigenous to the particular site, which is totally benign.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25. Characteristics of tumours • Majority of neoplasms can be categorized clinically and morphological into benign and malignant on the basis of certain characteristics listed bellow – Rate of growth – Cancer phenotype and stem cells – Clinical and gross features – Microscopic features – Local invasion (direct spread) – Metastasis (distant spread)
  • 26. Characteristics of tumours • Rate of growth – The tumour cell proliferate more rapidly than the normal cells. – The tumour enlarge rate is depends upon 1. Rate of cell production, growth fraction and rate of cell loss 2. Degree of differentiation of the tumour 1. Rate of growth of a tumour depends upon • Doubling time (mitotic rate) of tumour cells • Number of cells remaining in preoperative pool (growth fraction) • Rate of loss of tumour cells by cell shedding Cancer cell do not follow the normal cell controls in cells, and are immortal. The cell division rate is high and center of tumor do not receive adequate nourishment and undergo ischemic necrosis, loss shedding. Death tumour cells appear as apoptotic figures and dividing tumours are seen as normal/ abnormal mitotic figure ultimately tumour grow in size.
  • 27. Characteristics of tumours • Rate of growth 2. Degree of differentiation • Rate of growth of malignant tumour is directly proportionate to the degree of differentiation. • Poorly differentiated tumours show aggressive growth pattern compare to better differentiated tumours. • Rarely, a malignant tumour may disappear spontaneously from the primary site, due to good host immune attack.
  • 28. Characteristics of tumours • Cancer phenotype and stem cells Cancer cells 1. disobey the growth control – proliferate rapidly 2. escape from death signals – immortality 3. imbalance between cell proliferation and cell death – excessive growth 4. lose differentiation properties – no function 5. are unstable – newer mutations 6. overrun their neighboring tissue – invade locally 7. have the ability to travel from the site of origin to other part of body – distant metastasis Cancer stem cells/ tumour-initiating cells have the properties of self-renewal, asymmetric replication and transdifferentiation (i.e. plasticity).
  • 29. Characteristics of tumours • Clinical and gross features – Benign tumour are generally slow growing and depending upon location remains asymptomatic (subcutaneous lipoma) or may cause serous symptoms (meningioma in the nervous system). Benign tumours are generally spherical or ovoid shape. – Malignant tumor grow rapidly, invade locally into deeper tissue and spread to distant sites (metastasis). Malignant tumours are usually irregular in shape, poor-circumscribed and extend into adjacent tissues.
  • 30. Characteristics of tumours • Microscopic features – Microscopic pattern – Cytomorphology of neoplastic cells – Tumor angiogenesis and stroma – Inflammatory reaction
  • 31. Characteristics of tumours • Local invasion (direct spread) – Benign: expand and push aside without invading, infiltrating or metastasising. – Malignant: expand, invasion, infiltration and destruction of the surrounding tissue. • Metastasis (distant spread) – Metastasis (meta= transformation, stasis= residence): spread of tumour by invasion. – Routes of metastasis • Lymphatic spread • Haematogenous spread • Spread along body cavities and natural passages
  • 32.
  • 33. Tumours grading Grading is based on (1) the degree of anaplasia (2) the rate of growth • Grade-I : Well-differentiated (less than 25% anaplastic cells) • Grade-II : Moderately-differentiated (25-50% anaplastic cells) • Grade-III : Moderately-differentiated (50-75% anaplastic cells) • Grade-IV : Poorly-differentiated or anaplastic (more than 75% anaplastic cells)
  • 34. Tumours staging • International TNM system is commonly used for solid tumours (less applicable to lymphomas and leukaemias). – T: Tumour (size of primary tumour), N: Nodes (local/ regional node involvement), M: Metastases (distant metastases) T0 No evidence of tumour N0 Regional lymph nodes not involved Tis Carcinoma in situ NX Regional lymph nodes can’t be assessed TX Tumour can’t be assessed N1-4 Progressive increase in number of local/ regional lymph nodes involved T1-4 Progressive increase in tumour size M0 No evidence of distant metastases MX distant metastases can’t be assessed M1-3 Increasing involvement of distant metastases